- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.01. | Kardigan raises $300m for cardio work, and other financings | ||
| 17.01. | AZ's Calquence gets first-line OK in mantle cell lymphoma | ||
| 16.01. | FDA bans red dye used in medicines over cancer risk | ||
| 16.01. | Bioptimus raises $41m for its genAI model for biology | ||
| 16.01. | Santhera preps UK Duchenne drug launch after NICE says yes | ||
| 16.01. | J&J files intravesical bladder cancer drug TAR-200 in US | ||
| 16.01. | Lilly nets a second FDA okay for Omvoh, in Crohn's disease | ||
| 15.01. | Keros pulls study of Winrevair rival after safety signal | ||
| 15.01. | Lilly trims sales forecast on weaker obesity/diabetes growth | ||
| 15.01. | FTC doubles down on PBM criticism in new report | ||
| 15.01. | Sling shoots at thyroid eye disease with its oral therapy | ||
| 15.01. | Obesity needs a new definition, says global commission | ||
| 14.01. | AIs can be used for fracture detection, says NICE | ||
| 14.01. | Grifols gets $21m award for Parkinson's biomarker hunt | ||
| 14.01. | FDA sets August date for subcutaneous Leqembi decision | ||
| 14.01. | Bayer gains ground in two-fronted Parkinson's offensive | ||
| 13.01. | Lilly nets Scorpion cancer drug in $2.5bn licensing deal | ||
| 13.01. | Regeneron, Illumina join $320m Truveta investment | ||
| 13.01. | J&J agrees $14.6bn takeover of CNS biotech Intra-Cellular | ||
| 13.01. | GSK confirms plan to buy cancer firm IDRx for $1bn | ||
| 13.01. | Nine-month-old obesity player Metsera files an IPO | ||
| 13.01. | Biogen offers to buy out wilting Sage for $442 million | ||
| 10.01. | Ouro makes debut with $120m for autoimmune disease TCEs | ||
| 10.01. | Algorithm spots common sleep disorder linked to dementia | ||
| 10.01. | CRISPR biotech Intellia cuts staff as it eyes 2027 launch |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
